by Jeff Kiger
A new joint venture between Mayo Clinic and Boston Scientific Corp. will open a business accelerator lab "to address unmet medical needs" in the One Discovery Square center in downtown Rochester. Mayo Clinic CEO Dr. Gianrico Farrugia and Boston Scientific CEO Mike Mahoney were to announce the project at noon today in the recently built One Discovery Square complex at the corner of Fourth Street Southwest and Second Avenue Southwest. The new research lab will be called Motion Medical. The lab is expected to open in the fall and will occupy about 1,800-square-feet of space in the 89,000-square-foot complex. It's unknown how many employees will staff the lab or if the project will bring new jobs to Rochester.
Reach: The Rochester Post-Bulletin is a daily newspaper that serves Rochester, Austin and its surrounding cities. The newspaper has a daily circulation of more than 30,000 and a weekend circulation of more than 36,000. The Post-Bulletin online has more than 440,000 unique visitors to its website each month.
Additional coverage: KAAL, KTTC, Twin Cities Business, MPR, KROC-Radio, Jamestown Sun, Mass Device, Medical Design & Outsourcing, Medical Device Network, Minne Inno, MedTech Dive, MedCity Beat, KIMT, FOX 47, Becker's Orthopedic & Spine
Context: Mayo Clinic and Boston Scientific Corp. have launched a new venture to accelerate the development of medical technology and new minimally invasive treatments for many health conditions that impede quality and longevity of life.
The accelerator, known as Motion Medical, will have its research facilities in One Discovery Square, the bioscience center in the Discovery Square research district. Both parties have committed millions of dollars over three years to develop and bring new solutions to the market to address unmet medical needs.
"Mayo Clinic is committed to accelerating the pace of discoveries to bring new technologies and treatments to patients faster," said Gianrico Farrugia, M.D., president and CEO of Mayo Clinic. "This collaboration and others like it will continue to strengthen Rochester and Minnesota as a biomedical innovation and economic powerhouse." You can read more about the announcement on Mayo Clinic News Network.
Contact: Duska Anastasijevic